Specific Reduction of Alcohol’s Motivational Properties by the Positive Allosteric Modulator of the GABAB Receptor, GS39783—Comparison With the Effect of the GABAB Receptor Direct Agonist, Baclofen
- 25 August 2008
- journal article
- research article
- Published by Wiley in Alcohol, Clinical and Experimental Research
- Vol. 32 (9) , 1558-1564
Abstract
Background: Activation of the GABAB receptor—either by means of direct agonists (like baclofen) or positive allosteric modulators (like GS39783)—has been observed to suppress alcohol drinking and reinforcement in rats and mice. The present study was conducted to assess and compare the effect of baclofen and GS39783 on the motivational properties of alcohol.Methods: Selectively bred Sardinian alcohol‐preferring (sP) rats were initially trained to respond on a lever (on an fixed ratio 4 schedule of reinforcement) to orally self‐administer alcohol (15%, v/v) or sucrose (3%, w/v) in daily 30‐minute sessions. Once lever‐responding reached stable levels, rats were exposed to sessions with a progressive ratio schedule of reinforcement. The effect of nonsedative doses of baclofen (0, 1, and 3 mg/kg, i.p.) and GS39783 (0, 25, 50, and 100 mg/kg, i.g.) on breakpoint for alcohol and sucrose (defined as the lowest response requirement not achieved by each rat and used as index of the motivational strength of alcohol and sucrose) was determined.Results: Baclofen administration resulted in a dose‐dependent decrease in breakpoint for alcohol; this effect was not specific, as baclofen also reduced—to a comparable extent—breakpoint for sucrose. Conversely, GS39783 administration resulted in a dose‐dependent and completely specific reduction in breakpoint for alcohol.Conclusions: The present results (i) confirm previous data on baclofen’s capacity to suppress, although nonspecifically, alcohol’s motivational properties, and (ii) extend to alcohol’s motivational properties the capacity of GS39783 to inhibit alcohol drinking and reinforcement in rats.Keywords
This publication has 47 references indexed in Scilit:
- Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled studyThe Lancet, 2007
- GABAergic modulation of binge-like ethanol intake in C57BL/6J micePharmacology Biochemistry and Behavior, 2007
- GABAB Receptor-Positive Modulation-Induced Blockade of the Rewarding Properties of Nicotine Is Associated with a Reduction in Nucleus Accumbens ΔFosB AccumulationThe Journal of Pharmacology and Experimental Therapeutics, 2007
- SUPPRESSION OF SYMPTOMS OF ALCOHOL DEPENDENCE AND CRAVING USING HIGH-DOSE BACLOFENAlcohol and Alcoholism, 2006
- Theγ‐Aminobutyric Acid‐B Receptor Agonist Baclofen Attenuates Responding for Ethanol in Ethanol‐Dependent RatsAlcohol, Clinical and Experimental Research, 2006
- GABAB Receptor-Positive Modulation Decreases Selective Molecular and Behavioral Effects of CocaineNeuropsychopharmacology, 2006
- The GABAB Receptor-Positive Modulator GS39783 and the GABAB Receptor Agonist Baclofen Attenuate the Reward-Facilitating Effects of Cocaine: Intracranial Self-Stimulation Studies in the RatNeuropsychopharmacology, 2005
- COMPLETE AND PROLONGED SUPPRESSION OF SYMPTOMS AND CONSEQUENCES OF ALCOHOL-DEPENDENCE USING HIGH-DOSE BACLOFEN: A SELF-CASE REPORT OF A PHYSICIANAlcohol and Alcoholism, 2004
- THE GABAB RECEPTOR AGONISTS BACLOFEN AND CGP 44532 PREVENT ACQUISITION OF ALCOHOL DRINKING BEHAVIOUR IN ALCOHOL-PREFERRING RATSAlcohol and Alcoholism, 2002
- Progressive Ratio as a Measure of Reward StrengthScience, 1961